Cargando…

Dengue vaccine development: status and future

Dengue, the most common arbovirus, represents an increasingly significant cause of morbidity worldwide, including in travelers. After decades of research, the first dengue vaccine was licensed in 2015: CYD-TDV, a tetravalent live attenuated vaccine with a yellow fever vaccine backbone. Recent analys...

Descripción completa

Detalles Bibliográficos
Autor principal: Wilder-Smith, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224137/
https://www.ncbi.nlm.nih.gov/pubmed/31784763
http://dx.doi.org/10.1007/s00103-019-03060-3